🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Egbert F. Smit

Leiden University Medical Center

ORCID: 0000-0002-7329-6995

MedicineImmunology and MicrobiologyEconomics, Econometrics and Finance

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial”.

Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial

The Lancet Oncology(2024)10.1016/s1470-2045(24)00064-0

N/A

3.7DataRank · unranked

164 citations

Enriqueta Felip, Dipesh Uprety, Misako Nagasaka, Kazuhiko Nakagawa, Luis Paz‐Ares +15 more

Frequent and Focal FGFR1 Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung Cancer

Science Translational Medicine(2010)10.1126/scitranslmed.3001451

N/A

1.0DataRank · unranked

823 citations

Martin L. Sos, Danila Seidel, Charles M. Perou, Thomas Zander, Johannes M. Heuckmann +66 more

BRAFV600E-mutant metastatic NSCLC: disease overview and treatment landscape

npj Precision Oncology(2024)10.1038/s41698-024-00552-7

N/A

0DataRank · unranked

38 citations

Rachel E. Sanborn, Marcelo V. Negrão, Aria Vaishnavi, Egbert F. Smit, David Planchard